Job Description
Reporting to the Director of Research and Development, the Senior Research Scientist will have responsibility for developing solid, pharmaceutical oral dosage forms, including pre-formulation and formulation development of generic and branded products. The successful candidate will conduct evaluations of new excipients and active drug compounds, develop solid oral, controlled release tablets and capsules, analyze physical and analytical data using IVIVC software, initiate and monitor stability data, and monitor developed products from the technical transfer through the production manufacturing stages. You will have the opportunity to assist in technology transfer from R & D to production and provide manufacturing support of assigned products.
Bachelor of Science in chemistry, pharmacy, engineering or related area, masters or PhD preferred. Two plus years of experience in solid dosage formulation is preferred. You must have detailed working knowledge of pharmaceutical ingredients, familiarity with manufacturing processing and testing equipment, knowledge and understanding of preformulation (solubility, stability, pKa values, polymorphism, drug/excipients interactions), and the ability to coordinate multiple projects/tasks. The successful candidate will be highly organized, detail-oriented, knowledgeable of Microsoft Office programs, statistical analysis and PK/PD predictive modeling. It is essential to have a comprehensive understanding of chemical and physical properties of active ingredients and excipients.
With 13 consecutive years of record revenues, KV Pharmaceutical Company (www.kvph.com), a high-growth organization, has reported a year-over-year net revenue increase of 35.7% to over $600 million for Fiscal 2008.
KV Pharmaceutical (NYSE: KVa/KVb), is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology-distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its emerging branded drug subsidiary. With more than 65 years in business, KV applies its 15 unique patent protected and proprietary drug delivery technologies to both the brand and generic/non-branded products.
KV is based in St. Louis, Missouri, which was recently named as a 2008 All-America City by the American City Business Journals, one of Forbes’ “200 Best Metropolitan Areas” in America in 2006. St. Louis was also named the second most affordable large metropolitan area in the country by the National Association of Home Builders in 2005. St. Louis offers a world-class medical community with over 50 general practice, teaching and research hospitals including Washington University and St. Louis University. St. Louis is also rich in education with more than a dozen nationally-recognized four-year universities.
KV Pharmaceutical provides a comprehensive benefits package including a 401(k) and profit-sharing, health, vision, and dental. We offer competitive salaries and stock options for many positions which have proven to be lucrative to many long-term KV employees.
(6674)
